Advertisement

Index by author

October 01, 2014; Volume 351,Issue 1

  1. Wang, Chia-Chuan

    1. Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372

  2. Wang, Hui

    1. Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1
      Shinji Yamazaki, Justine L. Lam, Helen Y. Zou, Hui Wang, Tod Smeal and Paolo Vicini
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 67-76; DOI: https://doi.org/10.1124/jpet.114.217141

  3. Wang, Su-Jane

    1. Cyclooxygenase 2 Inhibitor Celecoxib Inhibits Glutamate Release by Attenuating the PGE2/EP2 Pathway in Rat Cerebral Cortex Endings
      Tzu-Yu Lin, Cheng-Wei Lu, Chia-Chuan Wang, Shu Kuei Huang and Su-Jane Wang
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 134-145; DOI: https://doi.org/10.1124/jpet.114.217372

  4. Watari, Akihiro

    1. Development of an Anti–Claudin-3 and -4 Bispecific Monoclonal Antibody for Cancer Diagnosis and Therapy
      Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 206-213; DOI: https://doi.org/10.1124/jpet.114.216911

  5. Watkinson, Lisa D.

    1. Relationship between Cerebral Sigma-1 Receptor Occupancy and Attenuation of Cocaine’s Motor Stimulatory Effects in Mice by PD144418
      John R. Lever, Dennis K. Miller, Emily A. Fergason-Cantrell, Caroline L. Green, Lisa D. Watkinson, Terry L. Carmack and Susan Z. Lever
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 153-163; DOI: https://doi.org/10.1124/jpet.114.216671

  6. Witkin, J. M.

    1. Perampanel, an Antagonist of α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptors, for the Treatment of Epilepsy: Studies in Human Epileptic Brain and Nonepileptic Brain and in Rodent Models
      R. Zwart, E. Sher, X. Ping, X. Jin, J. R. Sims, A. S. Chappell, S. D. Gleason, P. J. Hahn, K. Gardinier, D. L. Gernert, J. Hobbs, J. L. Smith, S. N. Valli and J. M. Witkin
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 124-133; DOI: https://doi.org/10.1124/jpet.114.212779

  7. Wong, Chi C.

    1. Pegylation Improves the Pharmacokinetics and Bioavailability of Small-Molecule Drugs Hydrolyzable by Esterases: A Study of Phospho-Ibuprofen
      George Mattheolabakis, Chi C. Wong, Yu Sun, Carol A. Amella, Robert Richards, Panayiotis P. Constantinides and Basil Rigas
      Journal of Pharmacology and Experimental Therapeutics October 2014, 351 (1) 61-66; DOI: https://doi.org/10.1124/jpet.114.217208
Back to top

In this issue

Advertisement